In HCC, inflammation-induced IgA+ cells directly inhibit cytotoxic CD8+ T cells in the liver by expressing programmed death-ligand 1 (PD-L1) and interleukin-10 (IL-10), thereby promoting tumor progression. Here, IL10 is linked to neoplasm.